Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
41
41 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- IRP101meta-fluorobenzylguanidine, 18F-MFBGPhase 34 trials
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · Cardiovascular Diseases, Heart Failure, Ischemic Cardiomyopathy
- buntanetapposiphenPhase 33 trials
Annovis Bio Inc. · Early Alzheimers Disease, Alzheimer's Dementia (AD), Parkinson's Disease (PD)
- PrasinezumabRO7046015, PRX002Phase 33 trials
Roche (Genentech) · Parkinson's Disease, Parkinsons Disease
- RadotinibSupect, IY5511Phase 33 trials
Il-Yang Pharm. Co., Ltd. · Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory
- TJ0113Phase 33 trials
Hangzhou PhecdaMed Co., Ltd. · Sarcopenia, Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
- AMX0035Phase 32 trials
Amylyx Pharmaceuticals Inc. · Wolfram Syndrome, Progressive Supranuclear Palsy, PSP
- CVN424Phase 32 trials
Cerevance · Parkinson Disease, Parkinson's Disease
- GM1Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Chemotherapy-induced Peripheral Neuropathy (CIPN), Parkinson's Disease
- ONO-2808Phase 32 trials
Ono Pharmaceutical Co., Ltd. · Multiple System Atrophy, Parkinson Variant, Multiple System Atrophy (MSA)
- bemdaneprocelMSK-DA01, BRT-DA01Phase 31 trial
BlueRock Therapeutics · Parkinsons Disease (PD)
- BHV-8000Phase 31 trial
Biohaven Therapeutics Ltd. · Parkinson Disease
- VG081821ACVG081821Phase 31 trial
Zhejiang Vimgreen Pharmaceuticals, Ltd. · Parkinson Disease (PD)
- Human Dopaminergic Progenitor CellsNouvNeu001Phase 23 trials
iRegene Therapeutics Co., Ltd. · Parkinson Disease, Parkinson Disease (PD)
- iPSChuman allogeneic induced pluripotent stem cell -derived dopaminergic neural progenitor cell, Allogeneic Human Induced Pluripotent Stem Cell -Derived Motor Neuron Progenitor CellsPhase 23 trials
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · Spinal Cord Injury, Safety, Efficacy
- AB-1005Phase 22 trials
AskBio Inc · PARKINSON DISEASE (Disorder), Parkinson Disease
- DNL151BIIB122Phase 22 trials
Denali Therapeutics Inc. · Parkinson Disease
- HBI-002Phase 22 trials
Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell
- NE3107bezisterimPhase 22 trials
BioVie Inc. · Long COVID, Parkinsons Disease (PD)
- RO7568282Phase 22 trials
Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease
- VIM0423Phase 22 trials
Vima Therapeutics · PARKINSON DISEASE (Disorder), Dystonia
- VTX3232Phase 22 trials
Zomagen Biosciences Ltd. · Idiopathic Parkinson Disease, Obesity
- VutiglabridinHSG4112Phase 22 trials
Glaceum · Knee Osteoarthritis (Knee OA), Parkinson Disease
- AP-472Phase 21 trial
Appello Pharmaceuticals, Inc. · Parkinson Disease
- ATR 1072Phase 21 trial
Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic
- BIA 28-6156Phase 21 trial
Bial R&D Investments, S.A. · Parkinson's Disease
- CPL500036Phase 21 trial
Celon Pharma SA · Parkinson Disease, Dyskinesia, Medication-Induced
- EC5026Phase 21 trial
EicOsis Human Health Inc. · Parkinson's Disease (PD)
- exidavnemabPhase 21 trial
BioArctic AB · Parkinson Disease, Multiple System Atrophy
- GT-02287GT-02287 400, GT-02287 800Phase 21 trial
Gain Therapeutics, Inc. · Parkinson Disease
- IRL757Phase 21 trial
Integrative Research Laboratories AB · PARKINSON DISEASE (Disorder), Apathy, Safety
- KDT-3594Phase 21 trial
Kissei Pharmaceutical Co., Ltd. · Parkinson Disease
- LY3884961Phase 21 trial
Prevail Therapeutics · Parkinson Disease
- MT101-5Phase 21 trial
Mthera Pharma Co., Ltd. · Parkinson's Disease
- ND0612ND0612HPhase 21 trial
NeuroDerm Ltd. · Parkinson's Disease
- NEU-411Phase 21 trial
Neuron23 Inc. · Parkinson Disease, Parkinson, Idiopathic Parkinson Disease
- NYX-458Phase 21 trial
Aptinyx · Mild Cognitive Impairment, Mild Dementia, Parkinson Disease
- RNDP-001Phase 21 trial
Kenai Therapeutics · Idiopathic Parkinson´s Disease, Parkinson's Disease
- SUL-238t.i.d.Phase 21 trial
GEN İlaç ve Sağlık Ürünleri A.Ş. · Parkinson's Disease (PD)
- TB006Phase 21 trial
TrueBinding, Inc. · Parkinson's Disease (PD)
- UCB0022Phase 21 trial
UCB · Parkinson Disease
- XJN010Phase 21 trial
Guangzhou Novaken Pharm Co., Ltd. · Parkinson Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.